News
The Food and Drug Administration (FDA) has approved Optison ™ (perflutren protein-type A microsphere) injectable suspension for use in pediatric patients with suboptimal echocardiograms to opacify the ...
Nature Made, CeraVe, and Neutrogena placed No. 1 in three or more categories for best OTC product. The companies with the most No. 1 products were Haleon (23), Kenvue Inc. (17), Prestige Consumer ...
Fresh & Ready Foods has voluntarily recalled products with “use by” dates from April 22 to May 19, 2025, CNN said. The items were sold under the brand names Fresh & Ready Foods, City Point Market ...
The investigational transdermal delivery system, known as Xulane Lo, is designed to deliver 150mcg of norelgestromin and 17.5mcg of ethinyl estradiol per day.
The Teal Wand is an at-home vaginal self-collection device intended to test for 14 types of high-risk HPV that have the ...
Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study.
Real-world benefit seen with addition of bevacizumab to first-line chemotherapy for patients with high‐risk prognostic factors.
Order expected to affect specific medications covered under Medicare that are administered in a health care setting.
Increased risk for attacks seen in women younger than 35 years, those with eosinophilia, those with lower corticosteroid use.
Topline data were announced from two phase 3 studies evaluating MR-107A-02 for the treatment of moderate to severe acute pain.
The 3 new color additives are Galdieria extract blue, butterfly pea flower extract, and calcium phosphate. HealthDay News — The US Food and Drug Administration announced the approval of 3 new color ...
The Food and Drug Administration (FDA) has cleared the Jewel ® Patch Wearable Cardioverter Defibrillator (Patch-WCD) for adult patients aged 18 years and older who are at risk for sudden cardiac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results